← All trials
NCT05137080
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2021
- Primary completion
- Jul 1, 2022
- Completion date
- Dec 31, 2022
- First posted
- Nov 30, 2021
- Last posted
- Nov 30, 2021
- Enrollment
- 252
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Southern DenmarkLead sponsor
- University of Southern DenmarkReponsible party - principal investigator
- Roskilde County HospitalStudy chair
- University of Southern DenmarkStudy chair
- University of CopenhagenStudy chair
- University of CopenhagenOverall official - principal investigator
- University of CopenhagenStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.